ClinVar Genomic variation as it relates to human health
NM_181523.3(PIK3R1):c.1945C>T (p.Arg649Trp)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_181523.3(PIK3R1):c.1945C>T (p.Arg649Trp)
Variation ID: 60763 Accession: VCV000060763.29
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 5q13.1 5: 68296301 (GRCh38) [ NCBI UCSC ] 5: 67592129 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 5, 2015 Oct 13, 2024 Jul 10, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_181523.3:c.1945C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_852664.1:p.Arg649Trp missense NM_001242466.2:c.856C>T NP_001229395.1:p.Arg286Trp missense NM_181504.4:c.1135C>T NP_852556.2:p.Arg379Trp missense NM_181524.2:c.1045C>T NP_852665.1:p.Arg349Trp missense NC_000005.10:g.68296301C>T NC_000005.9:g.67592129C>T NG_012849.2:g.85546C>T LRG_453:g.85546C>T LRG_453t1:c.1945C>T LRG_453p1:p.Arg649Trp P27986:p.Arg649Trp - Protein change
- R649W, R379W, R286W, R349W
- Other names
- -
- Canonical SPDI
- NC_000005.10:68296300:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
PIK3R1 | - | - |
GRCh38 GRCh37 |
546 | 562 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (8) |
criteria provided, multiple submitters, no conflicts
|
Jul 10, 2024 | RCV000054534.48 | |
Pathogenic (1) |
criteria provided, single submitter
|
Apr 18, 2022 | RCV000414540.14 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
May 3, 2022 | RCV000515192.17 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
Jan 1, 2016 | RCV001197921.10 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 13, 2017 | RCV001265992.10 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(May 13, 2014)
|
criteria provided, single submitter
Method: clinical testing
|
SHORT syndrome
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
unknown
|
UCLA Clinical Genomics Center, UCLA
Study: CES
Accession: SCV000255437.2 First in ClinVar: Oct 11, 2015 Last updated: Oct 11, 2015 |
Age: 0-9 years
Sex: female
Testing laboratory: UCLA Clinical Genomics Center
|
|
Pathogenic
(Oct 01, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
SHORT syndrome
Affected status: yes
Allele origin:
unknown
|
Laboratory of Medical Genetics, National & Kapodistrian University of Athens
Accession: SCV001976993.1
First in ClinVar: Oct 16, 2021 Last updated: Oct 16, 2021 |
Comment:
PS3, PM1, PM2, PP3, PP5
|
|
Pathogenic
(Apr 18, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000490990.4
First in ClinVar: Jan 09, 2017 Last updated: Mar 04, 2023 |
Comment:
Published functional studies demonstrate that the R649W results in a decrease in phosphotyrosine and IRS1-associated PI3K activity and impaired insulin signaling (Chudasama et al., 2013; … (more)
Published functional studies demonstrate that the R649W results in a decrease in phosphotyrosine and IRS1-associated PI3K activity and impaired insulin signaling (Chudasama et al., 2013; Barcena et al., 2014); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27766312, 23810382, 23810378, 23980586, 23810379, 24886349, 26974159, 27441994, 28632845, 29476696, 31829210, 31583022, 31836692, 32879144, 32602265, 34249805, 34008892, 33657699, 34026551) (less)
|
|
Pathogenic
(Jul 10, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
SHORT syndrome
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
unknown
|
Institute of Human Genetics, University of Leipzig Medical Center
Accession: SCV005368188.1
First in ClinVar: Oct 13, 2024 Last updated: Oct 13, 2024 |
Comment:
Criteria applied: PS3,PS4,PM2_SUP,PP3
Clinical Features:
Combined immunodeficiency (present)
Sex: female
|
|
Pathogenic
(May 18, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
SHORT syndrome
Agammaglobulinemia 7, autosomal recessive Immunodeficiency 36
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000611295.1
First in ClinVar: Nov 11, 2017 Last updated: Nov 11, 2017 |
|
|
Likely pathogenic
(Jan 01, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Immunodeficiency 36
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001368705.2
First in ClinVar: Jul 06, 2020 Last updated: Jul 06, 2020 |
Comment:
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PP3.
|
|
Pathogenic
(May 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
SHORT syndrome
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002521337.1
First in ClinVar: Jun 05, 2022 Last updated: Jun 05, 2022 |
Comment:
The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product … (more)
The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.97; 3Cnet: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000060763). The variant has been reported to co-segregate with the disease in at least 7 similarly affected relatives/individuals in at least two unrelated families (PMID: 23810382, 269880). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Short stature (present) , Small for gestational age (present)
|
|
Pathogenic
(Jul 13, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Inborn genetic diseases
Affected status: yes
Allele origin:
germline
|
Ambry Genetics
Accession: SCV001444164.2
First in ClinVar: Nov 21, 2020 Last updated: Jan 07, 2023 |
Number of individuals with the variant: 1
Clinical Features:
Overlapping fingers (present) , Hypertonia (present) , Frontal bossing (present) , Triangular face (present) , Short stature (present) , Wide anterior fontanel (present) , Short … (more)
Overlapping fingers (present) , Hypertonia (present) , Frontal bossing (present) , Triangular face (present) , Short stature (present) , Wide anterior fontanel (present) , Short nose (present) , Downslanted palpebral fissures (present) (less)
Sex: male
Ethnicity/Population group: Caucasian/Irish/French
|
|
Pathogenic
(May 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
SHORT syndrome
Immunodeficiency 36 Agammaglobulinemia 7, autosomal recessive
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000827309.4
First in ClinVar: Oct 10, 2018 Last updated: Feb 28, 2024 |
Comment:
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 649 of the PIK3R1 protein … (more)
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 649 of the PIK3R1 protein (p.Arg649Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of SHORT syndrome (PMID: 23810378, 23810379, 23810382, 23980586, 24886349, 25326637, 27766312). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 60763). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PIK3R1 protein function. Experimental studies have shown that this missense change affects PIK3R1 function (PMID: 23810379, 26974159, 27766312, 28632845). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Jul 11, 2013)
|
no assertion criteria provided
Method: literature only
|
SHORT SYNDROME
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000083012.2
First in ClinVar: Aug 28, 2013 Last updated: Aug 22, 2016 |
Comment on evidence:
In 5 patients from 4 families with SHORT syndrome (269880), including a patient previously reported by Bonnel et al. (2000), Thauvin-Robinet et al. (2013) identified … (more)
In 5 patients from 4 families with SHORT syndrome (269880), including a patient previously reported by Bonnel et al. (2000), Thauvin-Robinet et al. (2013) identified heterozygosity for a c.1945C-T transition at chr5:67,592,129 (GRCh37) in the PIK3R1 gene, resulting in an arg649-to-trp (R649W) substitution at a highly conserved residue in the cSH2 domain. In the 1 family for which parental DNA was available, the mutation was shown to be de novo. Thauvin-Robinet et al. (2013) noted that the c.1945C-T mutation occurred within the context of a CpG dinucleotide, which might explain its recurrence. In affected members of a 3-generation Norwegian family with SHORT syndrome, originally described by Aarskog et al. (1983), and a German mother and son with SHORT syndrome, originally reported by Koenig et al. (2003), Chudasama et al. (2013) identified heterozygosity for the R649W missense mutation in the PIK3R1 gene. The mutation was not found in 340 Norwegian controls. Haplotype analysis showed that the mutations resided on different backgrounds in the 2 families, indicating that they stemmed from 2 independent mutational events. Analysis of patient fibroblasts and reconstituted Pik3r1-knockout preadipocytes demonstrated impaired interaction between p85-alpha and IRS1 (147545) and reduced AKT (see 164730)-mediated insulin signaling. In a mother and 2 sons from an English family with SHORT syndrome, originally reported by Bankier et al. (1995) and restudied by Reardon and Temple (2008), and in an unrelated male patient, Dyment et al. (2013) identified heterozygosity for the R649W mutation in the PIK3R1 gene. (less)
|
|
Pathogenic
(Jul 18, 2018)
|
no assertion criteria provided
Method: clinical testing
|
SHORT syndrome
Affected status: yes
Allele origin:
de novo
|
Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals
Accession: SCV000898155.1
First in ClinVar: Apr 22, 2019 Last updated: Apr 22, 2019 |
|
|
Pathogenic
(Jun 09, 2021)
|
no assertion criteria provided
Method: clinical testing
|
SHORT syndrome
Affected status: yes
Allele origin:
germline
|
Genetic Services Laboratory, University of Chicago
Accession: SCV002072027.3
First in ClinVar: Jan 29, 2022 Last updated: Dec 11, 2022 |
Comment:
DNA sequence analysis of the PIK3R1 gene demonstrated a sequence change, c.1945C>T, in exon 15 that results in an amino acid change, p.Arg649Trp. This sequence … (more)
DNA sequence analysis of the PIK3R1 gene demonstrated a sequence change, c.1945C>T, in exon 15 that results in an amino acid change, p.Arg649Trp. This sequence change has not been described in population databases (dbSNP rs397515453). The p.Arg649Trp change affects a highly conserved amino acid residue located in a domain of the PIK3R1 protein that is known to be functional. The p.Arg649Trp substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change is a well-described missense variant that has previously been reported in multiple individuals with SHORT syndrome (PMID: 23810382, 23810379, 31829210, 29476696, 27766312, 32879144, 23980586, 32602265). Additionally, experimental studies have shown that this missense change impacts the function of the PIK3R1 protein (PMID: 27766312, 28632845, 23810379, 26974159). (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
SHORT syndrome
Affected status: yes
Allele origin:
germline
|
GeneReviews
Accession: SCV000148015.2
First in ClinVar: Oct 11, 2015 Last updated: Oct 01, 2022 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Phenotype-driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders. | Marinakis NM | American journal of medical genetics. Part A | 2021 | PMID: 34008892 |
SHORT Syndrome. | Adam MP | - | 2020 | PMID: 24830046 |
Iris Malformation and Anterior Segment Dysgenesis in Mice and Humans With a Mutation in PI 3-Kinase. | Solheim MH | Investigative ophthalmology & visual science | 2017 | PMID: 28632845 |
Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations. | Huang-Doran I | JCI insight | 2016 | PMID: 27766312 |
PI3-kinase mutation linked to insulin and growth factor resistance in vivo. | Winnay JN | The Journal of clinical investigation | 2016 | PMID: 26974159 |
De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly. | Kuhlen M | Clinical immunology (Orlando, Fla.) | 2016 | PMID: 26529633 |
Clinical exome sequencing for genetic identification of rare Mendelian disorders. | Lee H | JAMA | 2014 | PMID: 25326637 |
Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome. | Bárcena C | BMC medical genetics | 2014 | PMID: 24886349 |
PIK3R1 mutations in SHORT syndrome. | Schroeder C | Clinical genetics | 2014 | PMID: 23980586 |
Mutations in PIK3R1 cause SHORT syndrome. | Dyment DA | American journal of human genetics | 2013 | PMID: 23810382 |
SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. | Chudasama KK | American journal of human genetics | 2013 | PMID: 23810379 |
PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. | Thauvin-Robinet C | American journal of human genetics | 2013 | PMID: 23810378 |
Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. | Conley ME | The Journal of experimental medicine | 2012 | PMID: 22351933 |
Nephrocalcinosis and disordered calcium metabolism in two children with SHORT syndrome. | Reardon W | American journal of medical genetics. Part A | 2008 | PMID: 18384141 |
SHORT syndrome. | Koenig R | Clinical dysmorphology | 2003 | PMID: 12514365 |
SHORT syndrome: a case with high hyperopia and astigmatism. | Bonnel S | Ophthalmic genetics | 2000 | PMID: 11135494 |
Absent iris stroma, narrow body build and small facial bones: a new association or variant of SHORT syndrome? | Bankier A | Clinical dysmorphology | 1995 | PMID: 8574420 |
Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes. | Aarskog D | American journal of medical genetics | 1983 | PMID: 6407320 |
A new desensitizing dentifrice: preliminary report. | Zinner DD | Journal of the American Dental Association (1939) | 1977 | PMID: 269880 |
click to load more click to collapse |
Text-mined citations for rs397515453 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.